Dr. Reddy’s Laboratories Acquires Progynova and Cyclo-Progynova Trademarks from Mercury Pharma Group
Key Highlights: Implications: Dr. Reddy’s gains...
Breaking developments shaping Indian pharma, biotech, and healthcare.
Fast, factual reporting on what just happened.
Updated continuously, without the clutter.
Key Highlights: Implications: Dr. Reddy’s gains...
Key Highlights: Implications: Anyra smashes Eylea pricing...
Key Highlights: Implications: DaVitri addresses India’s...
Key Highlights: Implications: The Ayush Grid and My Ayush portal...
Key Highlights: Implications: Lilly’s India...
Key Highlights: Implications: PEPAIR smashes cost barriers to...
Key Highlights: Implications: CANTAB’s India entry taps the...
Key Highlights: Implications: Sanofi’s Hyderabad bet...
Key Highlights: Implications: India’s GATINN catapults...
Key Highlights: Implications: Imfinzi storms endometrial...